This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Ventilatory modalities in cardiogenicshock: insights from the AltShock-2 registry. Aims To describe the use and the relation to outcome of different ventilation strategies in a contemporary, large, prospective registry of cardiogenicshock patients. The 60-day mortality rates were 40.2%
Introduction The use of venoarterial extracorporeal membrane oxygenation (VA-ECMO) in extracorporeal cardiopulmonary resuscitation (ECPR) in selected patients after out-of-hospital cardiacarrest (OHCA) is an established method if return of spontaneous circulation cannot be achieved.
Impella and venoarterial extracorporeal membrane oxygenation (VA-ECMO) in patients with acute myocardial infarction-related cardiogenicshock (AMICS). Impella patients were older (34% vs. 13% >75 years, p < 0.001) and less frequently presented after an out-of-hospital cardiacarrest (18% vs. 40%, p < 0.001).
Introduction The use of venoarterial extracorporeal membrane oxygenation (VA-ECMO) in extracorporeal cardiopulmonary resuscitation (eCPR) has emerged as a treatment option for selected patients who are experiencing refractory cardiacarrest (CA).
We aimed to investigate the prevalence and outcomes of patients with SMuRF-less ACS undergoing percutaneous coronary intervention (PCI) compared with those with SMuRFs. The primary outcome was 30-day mortality. Secondary outcomes included in-hospital and 30-day events. Patients with coronary artery disease were excluded.
As heart failure with preserved ejection fraction (HFpEF) comprises half of all heart failure cases, understanding its management and effect on outcomes is crucial. There was a non-significant increased risk of cardiogenicshock (aOR 1.14, 95% CI 0.87 - 1.5, adjusted odds ratio [aOR] 1.01, 95% CI 0.85 - 1.2,
Patient characteristics, outcomes, and procedural volume were compared among 3 cohorts: admissions to non-ATCs, admissions to ATCs, and transfers to ATCs. A secondary analysis evaluated outcomes for severe HF hospitalizations (cardiogenicshock, cardiacarrest, and mechanical ventilation).
Circulation: Cardiovascular Quality and Outcomes, Ahead of Print. Admissions to CICUs with the highest tertile of CCRx utilization had a greater burden of comorbidities, had more diagnoses of ST–elevation myocardial infarction, cardiacarrest, or cardiogenicshock, and had higher Sequential Organ Failure Assessment scores.
About an hour later, he was then found on the floor in cardiacarrest in the ED. He underwent CPR and then was shocked out of VF. He was in cardiogenicshock requiring an impella for several days after cath. His initial troponin T was 15 ng/L (only two hours since pain onset). No further troponins were measured.
An elderly man with sudden cardiogenicshock, diffuse ST depressions, and STE in aVR Literature 1. Thirty-six patients (36%) presented with cardiacarrest, and 78% (28/36) underwent emergent angiography. As a result — cardiac cath was not performed — since results of a cath would not have altered the unfortunate outcome.
BACKGROUND:There are limited large-scale data on the outcomes of patients with cardiogenicshock (CS) transferred to hub centers. This was consistent across subgroups of CS cause, age, sex, hospital location, mechanical circulatory support use, and presence of cardiacarrest.
Aims Among patients with cardiogenicshock, immediate initiation of extracorporeal membrane oxygenation (ECMO) did not demonstrate any benefit at 30days. The present study evaluated 1-year clinical outcomes of the Extracorporeal Membrane Oxygenation in the therapy of CardiogenicShock (ECMO-CS) trial.
BACKGROUND:In patients with ST-segment–elevation myocardial infarction complicated by cardiogenicshock, primary percutaneous coronary intervention (pPCI) is the preferred revascularization option. The incidence of the primary safety outcome was 10.1% pharmacoinvasive and 46.2% pharmacoinvasive and 46.2% 1.09];P=0.08).CONCLUSIONS:In
Lactate was 20, POC Cardiac US showed EF estimated at 30%, and formal echo showed EF of only 15%, and a normal RV. Assessment was severe sudden cardiogenicshock. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. They recorded an EC G: New ST Elevation. What is it?
BackgroundVenoarterial extracorporeal membrane oxygenation (ECMO) provides full hemodynamic support for patients with cardiogenicshock, but optimal timing of ECMO initiation remains uncertain. Among 8619 patients (median, 56.7 women), the median duration from admission to ECMO initiation was 14 (5–32) hours. 1.36];P=0.004).
BackgroundMultidisciplinary teams and regionalized care systems have been suggested to improve cardiogenicshock (CS) outcomes. Journal of the American Heart Association, Ahead of Print. Methods and ResultsConsecutive patients with CS were evaluated (N=1162).
However, the association of socioeconomic vulnerability and outcomes after hospitalization is uncertain.Methods and ResultsAmerican Heart Association COVID19 Cardiovascular Disease Registry hospitalizations between March 1, 2020, and June 30, 2022, linked with Medicare feeforservice claims, were analyzed.
Background:Cardiogenic shock (CS) has high morbidity and mortality rates. Regardless of CS type, Black patients were more likely to have cardiacarrest during hospitalization. Circulation, Volume 150, Issue Suppl_1 , Page A4145617-A4145617, November 12, 2024. 0.93), pLVAD (aOR: 0.79, 95%CI: 0.72-0.86),
The primary outcome was 30-day MACE, including all-cause death, recurrent myocardial infarction, urgent target vessel revascularization, stroke, cardiogenicshock, and cardiacarrest (CA). The average age of the patients was 65.23 ± 12.66 years, The median AG levels were 7.60 mmol/L mmol/L (interquartile range: 6.30–10.20).
This study aims to identify the incidence and predictors for procedural intubation during PCI.Methods and ResultsA retrospective cohort study was performed on patients undergoing PCI between 2014 and 2021 within the Victorian CardiacOutcomes Registry.
ECG#1 ECG#2 ECG#3 ECG#4 ECG#5 See outcomes of all 5 below, with the Queen of Hearts AI Bot interpretation. The patient died of cardiogenicshock within 24 hours despite mechanical circulatory support. Smith: This bizarre ECG looks like a post cardiacarrest ECG with probable acidosis or hyperkalemia in addition to OMI.
BackgroundTraumatic cardiacarrest (TCA) poses significant challenges in resuscitation, with extremely high mortality rates, making it a critical issue in emergency and critical care medicine. The patient experienced cardiacarrest upon admission to a local hospital.
They felt that the asystolic arrest suggested a different etiology of cardiacarrest. With the severe acidosis and absence of ST elevation, they felt there was more likely to be a non-cardiac etiology of his presentation. Assessment : Cardiology thought this was cardiogenicshock from RV dysfunction.
1) as far as I can tell, there is very little data on amiodarone for this indication 2) amiodarone has beta blockade effects which could be deleterious in a patient with large anterior MI with pulmonary edema and at risk for cardiogenicshock (and she did go into shock. Smida T et al. DOI: 10.1016/j.resuscitation.2025.110515
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content